View in EDS

CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager.

Saved in:
Bibliographic Details
Title: CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager.
Authors: Bagheri A; Maverick Therapeutics, a Subsidiary of Takeda Pharmaceuticals, 3260 Bayshore Blvd., Brisbane, CA, 94118, USA., Culp PA; Maverick Therapeutics, a Subsidiary of Takeda Pharmaceuticals, 3260 Bayshore Blvd., Brisbane, CA, 94118, USA., DuBridge RB; Maverick Therapeutics, a Subsidiary of Takeda Pharmaceuticals, 3260 Bayshore Blvd., Brisbane, CA, 94118, USA., Chen TT; Maverick Therapeutics, a Subsidiary of Takeda Pharmaceuticals, 3260 Bayshore Blvd., Brisbane, CA, 94118, USA.
Source: Biochemistry and biophysics reports [Biochem Biophys Rep] 2022 Jan 12; Vol. 29, pp. 101205. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101660999 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-5808 (Electronic) Linking ISSN: 24055808 NLM ISO Abbreviation: Biochem Biophys Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35071801
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bagheri+A%22">Bagheri A</searchLink>; Maverick Therapeutics, a Subsidiary of Takeda Pharmaceuticals, 3260 Bayshore Blvd., Brisbane, CA, 94118, USA.<br /><searchLink fieldCode="AU" term="%22Culp+PA%22">Culp PA</searchLink>; Maverick Therapeutics, a Subsidiary of Takeda Pharmaceuticals, 3260 Bayshore Blvd., Brisbane, CA, 94118, USA.<br /><searchLink fieldCode="AU" term="%22DuBridge+RB%22">DuBridge RB</searchLink>; Maverick Therapeutics, a Subsidiary of Takeda Pharmaceuticals, 3260 Bayshore Blvd., Brisbane, CA, 94118, USA.<br /><searchLink fieldCode="AU" term="%22Chen+TT%22">Chen TT</searchLink>; Maverick Therapeutics, a Subsidiary of Takeda Pharmaceuticals, 3260 Bayshore Blvd., Brisbane, CA, 94118, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101660999%22">Biochemistry and biophysics reports</searchLink> [Biochem Biophys Rep] 2022 Jan 12; Vol. 29, pp. 101205. <i>Date of Electronic Publication: </i>2022 Jan 12 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101660999 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2405-5808 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224055808%22">24055808 </searchLink><i>NLM ISO Abbreviation: </i>Biochem Biophys Rep <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35071801
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.bbrep.2022.101205
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101205
    Titles:
      – TitleFull: CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bagheri A
      – PersonEntity:
          Name:
            NameFull: Culp PA
      – PersonEntity:
          Name:
            NameFull: DuBridge RB
      – PersonEntity:
          Name:
            NameFull: Chen TT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 01
              Text: 2022 Jan 12
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2405-5808
          Numbering:
            – Type: volume
              Value: 29
          Titles:
            – TitleFull: Biochemistry and biophysics reports
              Type: main
ResultId 1